Home > Healthcare > Medical Devices > Diagnostic Devices > Self-monitoring Blood Glucose Devices Market
Self-monitoring Blood Glucose Devices Market Share
- Report ID: GMI2743
- Published Date: Mar 2023
- Report Format: PDF
Self-monitoring Blood Glucose Devices Market Share
Some of the leading companies in the self-monitoring blood glucose devices market include
- Abbott Laboratories
- AgaMatrix
- Arkray, Inc.
- All Medicus Co., Ltd.
- Ascensia Diabetes Care Holdings AG
- B. Braun Melsungen AG
- Dexcom, Inc.
- Johnson & Johnson (Lifescan, Inc.)
- F. Hoffmann-La Roche Ltd.
- Medtronic Plc
- Nova Biomedical, Inc.
- Sinocare Inc.
- Essenlife Bioscience, Inc.
- DarioHealth Corp.
- Bionime Corporation
These firms are focusing on strategic alliances to achieve competitive benefits whilst amplifying their revenues.
Frequently Asked Questions (FAQ) :
Global market for self-monitoring blood glucose devices was worth more than USD 24.3 billion in 2022 and is anticipated to expand at over 9.5% CAGR from 2023-2032.
Type 2 diabetes applications is poised to surpass USD 57.8 billion by 2032 driven by the increasing disease burden of type 2 diabetes.
Europe self-monitoring blood glucose devices market size is anticipated to exhibit 9.5% CAGR between 2023-2032 driven by the growing government initiatives to boost diabetes care.
Arkray, Inc., AgaMatrix, All Medicus Co., Ltd., Dexcom, Inc., Medtronic Plc, Sinocare Inc., Nova Biomedical, Inc., and DarioHealth Corp are some of the key providers of self-monitoring blood glucose devices.
Self-monitoring Blood Glucose Devices Market Scope
×
Get a free sample of
Self-monitoring Blood Glucose Devices Market
Inquiry Before Buying
Get special pricing options on this report
Request Sectional Data
Over 70% of our clients customize reports to fit their needs. Please tell us how you would like to customize yours
below